Bracht Karin, Liebeke Manuel, Ritter Christoph A, Grünert Renate, Bednarski Patrick J
Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Anticancer Drugs. 2007 Apr;18(4):389-404. doi: 10.1097/CAD.0b013e3280140001.
The aim of this work was to determine the functional activities of four different antioxidative enzymes (glutathione reductase, glutathione-S-transferase, glutathione peroxidase, thioredoxin reductase) and the protein expression of three ATP-binding cassette transporters (P-glycoprotein, multidrug resistance protein 1, multidrug resistance protein 2) in a panel of 14 human cancer cell lines. Enzyme activities and transporter expression were then correlated with the in-vitro cytotoxic activities (GI50 values) of 19 standard antitumor drugs. Analogous data from the National Cancer Institute were used for comparison. The GI50 values of the platinum complexes, alkylating agents, antimetabolites, topoisomerase inhibitors and antimitotic drugs were determined by crystal violet or 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide assay. Standard enzymatic assays employed to measure the glutathione peroxidase, glutathione-S-transferase, glutathione reductase and thioredoxin reductase activities. The protein expression of the ATP-binding cassette transporter proteins was investigated by the Western-blot method. The delta method was used to normalize the data before bivariant correlation analysis. Only a few correlations between enzyme and cytotoxic activities of the antitumor agents were found. The GI50 values for melphalan and camptothecin correlated positively with the activity of glutathione-S-transferase, whereas GI50 values for methotrexate correlated positively with the cellular activities of both glutathione reductase and thioredoxin reductase. A significant correlation between glutathione reductase and thioredoxin reductase activities was found in our panel of cell lines. Neither P-glycoprotein nor multidrug resistance protein 2 expression could be detected by Western blot analysis in any cell lines investigated, but multidrug resistance protein 1 was consistently observed in all but four lines. Multidrug resistance protein 1 expression correlates positively with the GI50 values of several drugs, e.g. vinblastine and etoposide, and negatively with the GI50 values of 5-fluorouracil. The results confirm the complexity of resistance to antitumor agents and show that the GSH-thioredoxin system alone is not a good indication of intrinsic resistance for many of these anticancer drugs.
本研究旨在测定14种人癌细胞系中四种不同抗氧化酶(谷胱甘肽还原酶、谷胱甘肽-S-转移酶、谷胱甘肽过氧化物酶、硫氧还蛋白还原酶)的功能活性以及三种ATP结合盒转运蛋白(P-糖蛋白、多药耐药蛋白1、多药耐药蛋白2)的蛋白表达。然后将酶活性和转运蛋白表达与19种标准抗肿瘤药物的体外细胞毒活性(GI50值)进行相关性分析。使用美国国立癌症研究所的类似数据进行比较。通过结晶紫或3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四氮唑法测定铂类复合物、烷化剂、抗代谢物、拓扑异构酶抑制剂和抗有丝分裂药物的GI50值。采用标准酶法测定谷胱甘肽过氧化物酶、谷胱甘肽-S-转移酶、谷胱甘肽还原酶和硫氧还蛋白还原酶的活性。通过蛋白质印迹法研究ATP结合盒转运蛋白的蛋白表达。在双变量相关性分析之前,使用德尔塔法对数据进行标准化。仅发现少数抗肿瘤药物的酶活性与细胞毒活性之间存在相关性。美法仑和喜树碱的GI50值与谷胱甘肽-S-转移酶的活性呈正相关,而甲氨蝶呤的GI50值与谷胱甘肽还原酶和硫氧还蛋白还原酶的细胞活性均呈正相关。在我们的细胞系组中发现谷胱甘肽还原酶和硫氧还蛋白还原酶活性之间存在显著相关性。在所研究的任何细胞系中,通过蛋白质印迹分析均未检测到P-糖蛋白和多药耐药蛋白2的表达,但除四个细胞系外,在所有细胞系中均始终观察到多药耐药蛋白1的表达。多药耐药蛋白1的表达与几种药物(如长春碱和依托泊苷)的GI50值呈正相关,与5-氟尿嘧啶的GI50值呈负相关。结果证实了抗肿瘤药物耐药性的复杂性,并表明仅谷胱甘肽-硫氧还蛋白系统不能很好地指示许多这些抗癌药物的内在耐药性。